Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 20, 2014

Study Completion Date

October 20, 2014

Conditions
Arthritis
Interventions
OTHER

Blood Draws for Serum Titers

All study subjects are receiving the Gardasil vaccine as part of their clinical care. The Gardasil vaccine is not given because of study participation. The study observes outcomes related to this clinical care. Study intervention consists of some blood samples taken to measure antibody and RNA titers. Other study specific procedures performed include Questionnaires and observational data.

Trial Locations (4)

44106

University Hospitals Medical Center, Cleveland

44109

MetroHealth Medical Center, Cleveland

44189

Cleveland Clinic, Cleveland

60637

University of Chicago, Chicago

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

MetroHealth System, Ohio

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

University of Chicago

OTHER

lead

University Hospitals Cleveland Medical Center

OTHER

NCT00573651 - Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis | Biotech Hunter | Biotech Hunter